The Incidence and Magnitude of Fibrinolytic Activation in Trauma Patients: a Rebuttal

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2013 Apr 19

PMID 23593973

Citations 4

Authors

C R Ramos

E E Moore

M L Manco-Johnson

C C Silliman

M C Chapman

A Banerjee

Affiliations

Soon will be listed here.

Citing Articles

Association of hyperfibrinolysis with poor prognosis in refractory circulatory arrest: implications for extracorporeal cardiopulmonary resuscitation.

Magomedov A, Kruse J, Zickler D, Kunz J, Koerner R, Piper S Br J Anaesth. 2024; 133(3):500-507.

PMID: 39025778 PMC: 11347786. DOI: 10.1016/j.bja.2024.05.034.

SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock.

Bunch C, Chang E, Moore E, Moore H, Kwaan H, Miller J Front Physiol. 2023; 14:1094845.

PMID: 36923287 PMC: 10009294. DOI: 10.3389/fphys.2023.1094845.

Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

Ilich A, Kumar V, Ferrara M, Henderson M, Noubouossie D, Jenkins D Thromb Res. 2021; 204:22-28.

PMID: 34111811 PMC: 8277746. DOI: 10.1016/j.thromres.2021.05.017.

Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.

Ozolina A, Strike E, Nikitina-Zake L, Jaunalksne I, Krumina A, Lacis R BMC Anesthesiol. 2015; 15:122.

PMID: 26340801 PMC: 4560913. DOI: 10.1186/s12871-015-0101-1.

References

Pruitt Jr B . Combat casualty care and surgical progress. Ann Surg. 2006; 243(6):715-29. PMC: 1570575. DOI: 10.1097/01.sla.0000220038.66466.b5. View

Hoffmann J, Kops O . Inhibition of desmoteplase-induced fibrinolytic activity in vitro. J Thromb Thrombolysis. 2005; 20(1):23-6. DOI: 10.1007/s11239-005-2465-4. View

Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle E, Peguet O . Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2010; 43(1):26-32. DOI: 10.1016/j.injury.2010.11.003. View

Hoffmann J, Vijgen M . Prevention of in vitro fibrinogenolysis during laboratory monitoring of thrombolytic therapy with streptokinase or APSAC. Blood Coagul Fibrinolysis. 1991; 2(2):279-84. DOI: 10.1097/00001721-199104000-00010. View

Osdoit S, Rosa J . Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. J Biol Chem. 2000; 276(9):6703-10. DOI: 10.1074/jbc.M008945200. View

Kang Y, Martin D, Marquez J, Lewis J, Bontempo F, Shaw Jr B . Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985; 64(9):888-96. PMC: 2979326. View

Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C . The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2012; 11(2):307-14. DOI: 10.1111/jth.12078. View

VON KAULLA K, Kaye H, VON KAULLA E, Marchioro T, Starzl T . Changes in blood coagulation. Arch Surg. 1966; 92(1):71-9. PMC: 3035840. DOI: 10.1001/archsurg.1966.01320190073016. View

A Smith A, Jacobson L, Miller B, Hathaway W, Manco-Johnson M . A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res. 2004; 112(5-6):329-37. DOI: 10.1016/j.thromres.2004.01.001. View

10.

Kowalski E, Kopec M, NIEWIAROWSKI . An evaluation of the euglobulin method for the determination of fibrinolysis. J Clin Pathol. 1959; 12(3):215-8. PMC: 479903. DOI: 10.1136/jcp.12.3.215. View

11.

Sauaia A, Moore F, Moore E, Moser K, Brennan R, Read R . Epidemiology of trauma deaths: a reassessment. J Trauma. 1995; 38(2):185-93. DOI: 10.1097/00005373-199502000-00006. View

12.

Katori N, Tanaka K, Szlam F, Levy J . The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography. Anesth Analg. 2005; 100(6):1781-1785. DOI: 10.1213/01.ANE.0000149902.73689.64. View

13.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

14.

Garabedian H, Gold H, Leinbach R, Yasuda T, Johns J, Thornton D . Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator. Thromb Res. 1988; 50(1):121-33. DOI: 10.1016/0049-3848(88)90180-6. View